Mary Ellen Vajravelu, MD
1 clinical trials · Sponsor
◉ Watch Mary Ellen Vajravelu, MD
| Record | Firm | Date |
|---|---|---|
| Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation (NCT05404711) | Mary Ellen Vajravelu, MD | 2022-10-11 |
Track Mary Ellen Vajravelu, MD automatically
Every clearance here is in the API, with alerts when new ones post.